Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 70 Lymphoma 50 Lymphoma, Large B-Cell, Diffuse 47 Lymphoma, Non-Hodgkin 28 Osteosarcoma 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Hodgkin Disease 24 Burkitt Lymphoma 19 Testicular Neoplasms 17 Leukemia 17 Ovarian Neoplasms 16 Lymphoma, Follicular 16 Neuroectodermal Tumors, Primitive, Peripheral 15 Lymphoma, Large-Cell, Immunoblastic 13 Fibrosarcoma 12 Rhabdomyosarcoma 11 Lymphoma, Mantle-Cell 11 Testicular Germ Cell Tumor 10 Teratoma 10 Recurrence 10 Neurofibrosarcoma 10 Lymphoma, B-Cell, Marginal Zone 10 Liposarcoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Leiomyosarcoma 10 Sarcoma, Synovial 9 Neoplasms 9 Lymphoma, Large-Cell, Anaplastic 9 Histiocytoma, Malignant Fibrous 9 Hemangiosarcoma 9

Interventions

Diathermy 16 Radiotherapy 9 Drug Therapy 4 Cisplatin 4 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 tislelizumab 2 Surgical Procedures, Operative 2 Radiation 2 Immunotherapy 2 Conization 2 Brachytherapy 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Solutions 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡